Conferences
2–5 March 2017, Cannes, France
The 7th International Conference on Fixed Combination Therapy in Cardiovascular Disease, Hypertension, Diabetes, Dyslipidemia and Cardio-Metabolic Syndrome
Fixed combination has become popular over the recent years. It enables us to treat the patients with smaller amounts of tablets, thus improving compliance and effectiveness of treatment. It simplifies treatment, may decrease costs and minimizes the likelihood of missed doses. In specific cases it enables us to give lower doses of each component drug and thus combination therapy may reduce side effects. As a result, fixed combination therapy has shown to improve adherence and patients’ clinical outcomes.
